Sinocare Inc.

Company Profile

1. Persistent R&D and innovation abilities The biosense technology applied in POCT industry involves many disciplines such as chemistry, physics, biology, medicine, materials science, and computer science, etc. The company has a multidisciplinary R&D team and a scientific R&D system. In response to the industrial development trend, the company created a blood glucose monitoring product with data transmission function, developed a blood glucose management system for patients inside and outside hospitals, and a “cloud hospital” information system for diabetes management to strengthen new product R&D, and create electrochemical platform, photochemical platform, fluorescence immunoassay platform and mobile medical platform. 2. Perfect quality control ability The company always regards product quality as the lifeline of enterprise development, strictly follows ISO 13485:2016 quality management system, and carries out product production and quality control according to requirements of GMP and FDA systems. Most products have passed the EU CE certification and some have been subject to application for the US FDA certification, among which, Gold AQ Blood Glucose Monitoring System has obtained the US FDA 510 (K) certification. 3. Powerful brand influence The blood glucose monitoring system produced by the company has been widely recognized by consumers. The company’s trademark “Sinocare” was recognized as a "well-known trademark" by the State Administration for Industry & Commerce in June 2015, and has a high brand influence in diabetic patients. The company actively carries out all-round brand promotion and publicity activities such as online and offline brand promotion, operation and media management to enhance user’s stickiness. 4. Excellent after-sale service system The company has established a sales and service system covering more than 100,000 terminals nationwide, and promised “lifelong maintenance and nationwide warranty” for blood glucose meter products. Considering that most products are for middle-aged and elderly users, the company continuously strengthens after-sales service management, carries out functional transformation from “health consultants” to “consultant marketing”, and implements “Member Wake-up Plan” and “Diabetic Discovery Program” to further improve membership services quality. 5. Complete blood glucose monitoring product line As a leading provider of blood glucose monitoring products and diabetes management services solution in China, the company currently has a relatively complete list of registered blood glucose monitoring products through over decade of R&D input in blood glucose monitoring products. Currently, the company’s product series include Safe AQ, Safe ACCU, Gold, dual-function EA-11 blood glucose & uric acid test system, mobile blood glucose meter and smart blood glucose monitoring system, etc. 6. Efficient management and talent incentive mechanism The company fully introduces and runs process management, basically realizing coverage of core businesses including research, production and sales; strengthens financial data integration and improves financial decision-making ability, carries out talent strategic management and long-term incentive system. The company implemented the employee stock ownership plan and restricted stock incentive program to achieve benefit consistency between the company, shareholders and employees, thereby bringing more efficient and lasting returns to shareholders. 7. Excellent advantage in resource integration PTS, a wholly-owned subsidiary of the company in the US, is mainly engaged in R&D, production and sales of POCT products. Its main products are CardioChek series for blood lipid monitoring system and A1CNow series for glycated hemoglobin (HbA1c) monitoring system, etc. After this reorganization, the listed company will expand product chain in real-time monitoring of blood lipids and glycated hemoglobin and accelerate the internationaliz